Ken Griffin Lantheus Holdings, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 36,700 shares of LNTH stock, worth $2.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,700

Previous 103,700 64.61%

Holding current value

$2.76 Million

Previous $9.28 Million 61.4%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$78.23 - $110.01 $1.14 Million - $1.6 Million	14,537 Added 9.73%	163,947 $16 Million
Q4 2024 Feb 14, 2025	BUY	$76.22 - $116.71 $11.4 Million - $17.4 Million	149,410 New	149,410 $13.4 Million
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $1.6 Million - $2.26 Million	-27,212 Reduced 8.24%	302,974 $24.3 Million
Q1 2024 May 15, 2024	SELL	$51.07 - $68.26 $28 Million - $37.4 Million	-548,368 Reduced 62.42%	330,186 $20.6 Million
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $40 Million - $56.1 Million	720,253 Added 454.99%	878,554 $54.5 Million
Q3 2023 Nov 14, 2023	SELL	$60.27 - $90.75 $4.9 Million - $7.38 Million	-81,297 Reduced 33.93%	158,301 $11 Million
Q2 2023 Aug 14, 2023	SELL	$82.41 - $99.65 $7.36 Million - $8.9 Million	-89,337 Reduced 27.16%	239,598 $20.1 Million
Q1 2023 May 15, 2023	SELL	$47.76 - $82.86 $21.1 Million - $36.6 Million	-441,543 Reduced 57.31%	328,935 $27.2 Million
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $37.6 Million - $59.8 Million	770,478 New	770,478 $39.3 Million
Q2 2022 Aug 15, 2022	SELL	$55.54 - $72.65 $20.2 Million - $26.4 Million	-363,232 Reduced 30.09%	843,747 $55.7 Million
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $24.5 Million - $57.1 Million	1,008,390 Added 507.78%	1,206,979 $66.8 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $2.04 Million - $2.76 Million	90,639 Added 83.96%	198,589 $5.74 Million
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $2.1 Million - $2.48 Million	86,861 Added 411.88%	107,950 $2.77 Million
Q2 2021 Aug 16, 2021	BUY	$19.51 - $27.64 $133,780 - $189,527	6,857 Added 48.18%	21,089 $582,000
Q1 2021 May 17, 2021	SELL	$13.77 - $21.66 $650,907 - $1.02 Million	-47,270 Reduced 76.86%	14,232 $304,000
Q4 2020 Feb 16, 2021	SELL	$10.75 - $14.91 $472,312 - $655,085	-43,936 Reduced 41.67%	61,502 $830,000
Q3 2020 Nov 16, 2020	SELL	$11.98 - $16.34 $264,578 - $360,868	-22,085 Reduced 17.32%	105,438 $1.34 Million
Q2 2020 Aug 14, 2020	SELL	$10.34 - $15.51 $849,038 - $1.27 Million	-82,112 Reduced 39.17%	127,523 $1.82 Million
Q1 2020 May 15, 2020	BUY	$9.11 - $20.05 $1.07 Million - $2.36 Million	117,735 Added 128.11%	209,635 $2.68 Million
Q4 2019 Feb 14, 2020	BUY	$18.47 - $24.03 $1.52 Million - $1.98 Million	82,447 Added 872.18%	91,900 $1.89 Million
Q3 2019 Nov 14, 2019	SELL	$21.01 - $28.94 $101,730 - $140,127	-4,842 Reduced 33.87%	9,453 $236,000
Q2 2019 Aug 14, 2019	SELL	$23.33 - $28.3 $279,703 - $339,288	-11,989 Reduced 45.61%	14,295 $404,000
Q1 2019 May 15, 2019	SELL	$14.93 - $25.1 $377,669 - $634,929	-25,296 Reduced 49.04%	26,284 $0
Q4 2018 Feb 14, 2019	BUY	$12.68 - $19.01 $392,686 - $588,720	30,969 Added 150.25%	51,580 $807,000
Q3 2018 Nov 13, 2018	SELL	$13.1 - $16.35 $251,231 - $313,560	-19,178 Reduced 48.2%	20,611 $0
Q2 2018 Aug 10, 2018	SELL	$13.65 - $18.7 $579,920 - $794,469	-42,485 Reduced 51.64%	39,789 $0
Q1 2018 May 11, 2018	BUY	$14.85 - $24.3 $1.22 Million - $2 Million	82,274 New	82,274 $1.31 Million

Others Institutions Holding LNTH

# of Institutions

576

Shares Held

77.1M

Call Options Held

498K

Put Options Held

186K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.16B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account